Global Spinal Muscular Atrophy Market Outlook 2018-2023 Industry Trends, Analysis, Opportunities, Segmentation and Forecast


 Published Date : Jul-2018  |   Publisher : Reports Buzz  |   Format : PDF

 Buy Now

This report studies the global Spinal Muscular Atrophy market, analyzes and researches the Spinal Muscular Atrophy development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Lonis Pharmaceuticals
    F. Hoffmann-La Roche
    AveXis
    Novartis
    Cytokinetics
    Ionis Pharmaceuticals
    ...

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    Early Stage Candidates
    Late Stage Candidates

Market segment by Application, Spinal Muscular Atrophy can be split into
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Spinal Muscular Atrophy Market Size, Status and Forecast 2025
1 Industry Overview of Spinal Muscular Atrophy
    1.1  Spinal Muscular Atrophy Market Overview
        1.1.1 Spinal Muscular Atrophy Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Spinal Muscular Atrophy Market Size and Analysis by Regions (2013-2018)
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Spinal Muscular Atrophy Market by Type
        1.3.1 Early Stage Candidates
        1.3.2 Late Stage Candidates
    1.4 Spinal Muscular Atrophy Market by End Users/Application
        1.4.1 Hospital
        1.4.2 Clinic
        1.4.3 Others

2 Global Spinal Muscular Atrophy Competition Analysis by Players
    2.1 Spinal Muscular Atrophy Market Size (Value) by Players (2013-2018)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Lonis Pharmaceuticals
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
        3.1.5 Recent Developments
    3.2 F. Hoffmann-La Roche
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
        3.2.5 Recent Developments
    3.3 AveXis
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
        3.3.5 Recent Developments
    3.4 Novartis
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
        3.4.5 Recent Developments
    3.5 Cytokinetics
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
        3.5.5 Recent Developments
    3.6 Ionis Pharmaceuticals
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Spinal Muscular Atrophy Revenue (Million USD) (2013-2018)
        3.6.5 Recent Developments

4 Global Spinal Muscular Atrophy Market Size by Type and Application (2013-2018)
    4.1 Global Spinal Muscular Atrophy Market Size by Type (2013-2018)
    4.2 Global Spinal Muscular Atrophy Market Size by Application (2013-2018)
    4.3 Potential Application of Spinal Muscular Atrophy in Future
    4.4 Top Consumer/End Users of Spinal Muscular Atrophy

5 United States Spinal Muscular Atrophy Development Status and Outlook
    5.1 United States Spinal Muscular Atrophy Market Size (2013-2018)
    5.2 United States Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
    5.3 United States Spinal Muscular Atrophy Market Size by Application (2013-2018)

6 EU Spinal Muscular Atrophy Development Status and Outlook
    6.1 EU Spinal Muscular Atrophy Market Size (2013-2018)
    6.2 EU Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
    6.3 EU Spinal Muscular Atrophy Market Size by Application (2013-2018)

7 Japan Spinal Muscular Atrophy Development Status and Outlook
    7.1 Japan Spinal Muscular Atrophy Market Size (2013-2018)
    7.2 Japan Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
    7.3 Japan Spinal Muscular Atrophy Market Size by Application (2013-2018)

8 China Spinal Muscular Atrophy Development Status and Outlook
    8.1 China Spinal Muscular Atrophy Market Size (2013-2018)
    8.2 China Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
    8.3 China Spinal Muscular Atrophy Market Size by Application (2013-2018)

9 India Spinal Muscular Atrophy Development Status and Outlook
    9.1 India Spinal Muscular Atrophy Market Size (2013-2018)
    9.2 India Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
    9.3 India Spinal Muscular Atrophy Market Size by Application (2013-2018)

10 Southeast Asia Spinal Muscular Atrophy Development Status and Outlook
    10.1 Southeast Asia Spinal Muscular Atrophy Market Size (2013-2018)
    10.2 Southeast Asia Spinal Muscular Atrophy Market Size and Market Share by Players (2013-2018)
    10.3 Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018)

11 Market Forecast by Regions, Type and Application (2018-2025)
    11.1 Global Spinal Muscular Atrophy Market Size (Value) by Regions (2018-2025)
        11.1.1 United States Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
        11.1.2 EU Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
        11.1.3 Japan Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
        11.1.4 China Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
        11.1.5 India Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
        11.1.6 Southeast Asia Spinal Muscular Atrophy Revenue and Growth Rate (2018-2025)
    11.2 Global Spinal Muscular Atrophy Market Size (Value) by Type (2018-2025)
    11.3 Global Spinal Muscular Atrophy Market Size by Application (2018-2025)

12 Spinal Muscular Atrophy Market Dynamics
    12.1 Spinal Muscular Atrophy Market Opportunities
    12.2 Spinal Muscular Atrophy Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Spinal Muscular Atrophy Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Spinal Muscular Atrophy Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source


List of Tables and Figures

    Figure Global Spinal Muscular Atrophy Market Size (Million USD) Status and Outlook (2013-2018)
    Table Global Spinal Muscular Atrophy Revenue (Million USD) Comparison by Regions (2013-2018)
    Figure Global Spinal Muscular Atrophy Market Share by Regions (2013-2018)
    Figure United States Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure EU Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Japan Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure China Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure India Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate by Regions (2013-2018)
    Table Global Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)
    Figure Global Spinal Muscular Atrophy Revenue Market Share by Type in 2017
    Figure Early Stage Candidates Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Late Stage Candidates Market Size (Million USD) and Growth Rate (2013-2018)
    Figure Global Spinal Muscular Atrophy Market Share by Application in 2017
    Figure Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate in Hospital (2013-2018)
    Figure Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate in Clinic (2013-2018)
    Figure Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate in Others (2013-2018)
    Table Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table Lonis Pharmaceuticals Basic Information List
    Table Spinal Muscular Atrophy Business Revenue (Million USD) of Lonis Pharmaceuticals (2013-2018)
    Figure Lonis Pharmaceuticals Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
    Table F. Hoffmann-La Roche Basic Information List
    Table Spinal Muscular Atrophy Business Revenue (Million USD) of F. Hoffmann-La Roche (2013-2018)
    Figure F. Hoffmann-La Roche Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
    Table AveXis Basic Information List
    Table Spinal Muscular Atrophy Business Revenue (Million USD) of AveXis (2013-2018)
    Figure AveXis Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
    Table Novartis Basic Information List
    Table Spinal Muscular Atrophy Business Revenue (Million USD) of Novartis (2013-2018)
    Figure Novartis Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
    Table Cytokinetics Basic Information List
    Table Spinal Muscular Atrophy Business Revenue (Million USD) of Cytokinetics (2013-2018)
    Figure Cytokinetics Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
    Table Ionis Pharmaceuticals Basic Information List
    Table Spinal Muscular Atrophy Business Revenue (Million USD) of Ionis Pharmaceuticals (2013-2018)
    Figure Ionis Pharmaceuticals Spinal Muscular Atrophy Business Revenue Market Share (2013-2018)
    Table Global Spinal Muscular Atrophy Market Size (Million USD) by Product (2013-2018)
    Figure Global Spinal Muscular Atrophy Revenue Market Share (%) by Product (2013-2018)
    Figure Global Spinal Muscular Atrophy Market Share by Product in 2017
    Table Global Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure Global Spinal Muscular Atrophy Revenue Market Share (%) by Application in 2017
    Table Top Consumer/End Users of Spinal Muscular Atrophy
    Figure United States Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
    Table United States Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure United States Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure United States Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table United States Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure United States Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
    Figure United States Spinal Muscular Atrophy Market Size Share by Application in 2017
    Figure EU Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
    Table EU Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure EU Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure EU Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table EU Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure EU Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
    Figure EU Spinal Muscular Atrophy Market Size Share by Application in 2017
    Figure Japan Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
    Table Japan Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure Japan Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure Japan Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table Japan Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure Japan Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
    Figure Japan Spinal Muscular Atrophy Market Size Share by Application in 2017
    Figure China Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
    Table China Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure China Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure China Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table China Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure China Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
    Figure China Spinal Muscular Atrophy Market Size Share by Application in 2017
    Figure India Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
    Table India Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure India Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure India Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table India Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure India Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
    Figure India Spinal Muscular Atrophy Market Size Share by Application in 2017
    Figure Southeast Asia Spinal Muscular Atrophy Market Size (Million USD) and Growth Rate (2013-2018)
    Table Southeast Asia Spinal Muscular Atrophy Market Size (Million USD) by Players (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Market Size Share by Players in 2013
    Figure Southeast Asia Spinal Muscular Atrophy Market Size Share by Players in 2017
    Table Southeast Asia Spinal Muscular Atrophy Market Size by Application (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Revenue Market Share (%) by Application (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Market Size Share by Application in 2017
    Figure Global Spinal Muscular Atrophy Market Size and Growth Rate (2018-2025)
    Table Global Spinal Muscular Atrophy Market Size (Million USD) by Regions (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size Share (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size Share by Regions in 2025
    Figure United States Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
    Figure EU Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Japan Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
    Figure China Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
    Figure India Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
    Figure Southeast Asia Spinal Muscular Atrophy Revenue (Million USD) and Growth Rate (2018-2025)
    Table Global Spinal Muscular Atrophy Market Size (Million USD) by Type (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size Share by Type in 2018
    Figure Global Spinal Muscular Atrophy Market Size Share by Type in 2025
    Table Global Spinal Muscular Atrophy Market Size (Million USD) by Application (2018-2025)
    Figure Global Spinal Muscular Atrophy Market Size (Million USD) by Application in 2018
    Figure Global Spinal Muscular Atrophy Market Size (Million USD) by Application in 2025



LATEST NEWS

Microsoft And Walgreen Alliance To Help Healthcare Market To Propel
 25-Feb-2019  /   Chemicals & Materials

The alliance between two or more unrelated business organizations has been pushing the market to the next level by supporting each other. Currently, Amazon has been expanding its business into different markets at global level comprising its e-commerce business, cloud computing, and healthcare also. Amazon is frightening above mentioned markets-based players to tie up for future survival.

New Turmeric Product Is Going To Enter The Global Spices Market
 25-Feb-2019  /   Chemicals & Materials

An innovative agricultural product prepared from turmeric, specifically grown in Belize, has entered the market with high customer demand. The product is gaining popularity in Canada and other regions of the Caribbean, along with Belize. This might facilitate the steep growth of global spices market. This discovery will not only expand the agricultural market capitalization but also increase th ...

Drop In Cashew Export Owing To Quality Issues Likely To Hamper Cashew Market Growth
 13-Feb-2019  /   Food & Beverage

A major glut along with poor turnover was confronted by merchants, traders, farmers, and other financiers in the cashew market in Kogi State in the 2018 farming season caused by heavy losses summed over N50 Billion. Kogi is the largest cashew-making state in Nigeria, shipping around 100 metric tonnes of cashew nuts out of the 220 metric tonnes exported by the whole nation yearly.






Our Clients

We are here to help you Get in touch quickly.

48 hours! That’s all you need to get a detailed market research of any specific industry.

/